Studies addressing the mechanisms underlying loss of function alterations in C/EBP gene expression demonstrated that the C/EBPδ gene promoter is silenced by promoter hypermethylation in the SUM-52PE human breast cancer cell line (26/27 CpGs methylated) and by site-specific methylation in primary human breast tumor isolates [11]. This evidence concerns the gene CEBPD and breast neoplasm.